Insights

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

  • Turning Treatment Barriers into Drivers

    Improved compliance and adherence can lead to better health outcomes for patients and brand growth for drug manufacturers, but convincing patients to accept treatment is a well-recognized challenge.

  • The Costly Impact of Implicit Questions

    Learn about a dangerous, hidden communication challenge facing patients and their healthcare providers. Then uncover ways for your brand to offer support by helping put patients on a path towards activation and adherence.

  • The Definitive Guide to Dialogue Research

    Whether you’re new to healthcare dialogue research or consider yourself an expert, the Definitive Guide to Dialogue Research will help you discover how natural exam-room conversations can be applied to build a stronger foundation for your brand marketing goals.

  • MM+M Game Changers 2023: Insagic Profile

    Verilogue is now part of Insagic, a Publicis Health company, is a groundbreaking insights and advisory business that combines data, design, and dialogues to deliver activatable insights and transformational intelligence that our clients need to succeed and grow in today’s…

  • Zach Hebert Named to Greenbook’s Future List 2023

    Insagic, a next-generation insights and advisory business that combines data, design, and dialogues, announced today that its Manager, Linguistic Insights & Analytics Zach Hebert has been named an honoree to the GreenBook Future List 2023.

  • Alzheimer’s Infographic 2022

    June is Alzheimer’s & Brain Awareness Month, dedicated to raising awareness for the more than 55 million people worldwide who are living with Alzheimer’s or another dementia. Verilogue’s RevealMR portal provides access to the largest healthcare dialogue database, enabling endless…

  • Migraine case study

    Success Story: Migraine

    June is Migraine & Headache Awareness Month, a time to champion advocacy and research, build community, and raise awareness for the 3.3 million people in the US (and those around the world) who are living with chronic migraine.

  • Equity in the Vaccination Process

    Click here to download the presentation Across the US, patients of color have a lower rate of flu vaccination than white patients. These disparities are consistent regardless of the overall flu vaccination rate, and with increased attention on the impact…

  • Ers 2021: Severe Asthma Patients’ Engagement Drives Treatment Decision-Making in Biologic Follow-Up Visits

    [vc_row][vc_column][vc_single_image image=”56323″ img_size=”large” alignment=”center” onclick=”custom_link” img_link_target=”_blank” link=”https://ww2.verilogue.com/rs/571-LBR-192/images/ERS 2021 Poster.pdf”][dt_quote]Lu, E., Solovyeva, K., Hebert, Z., Kietzer, L., Griffiths, S., Eid Antoun, Z., Keeley, T., & Alfonso-Cristancho, R., (2021, September 5-8). Shared decision making in severe asthma therapy: Qualitative study of physician-patient…

  • WEBINAR: The Impact of COVID on Physician Legitimacy and Patient Empowerment

    COVID-19 has radically changed healthcare. Some of these changes are temporary workarounds. Some are here to stay. And some already were in place, with COVID accelerating the changes. All of the changes have had an impact on patient behavior: how…

  • Unpacking Vaccine Hesitancy: Perspectives at the Point of Care

    [vc_row][vc_column][vc_column_text css=”.vc_custom_1620250401630{margin-bottom: 15px !important;}”] Whitepaper When the COVID-19 pandemic began in early 2020, there was widespread concern about how fast an effective vaccine could be developed – if one could be developed at all. As we move into Spring 2021…

  • Risk in the Age of COVID-19

    [vc_row][vc_column][vc_column_text css=”.vc_custom_1620251239488{margin-bottom: 15px !important;}”] Whitepaper In the exam room, discussion of risks associated with COVID-19 are evolving as we learn more about the underlying characteristics of the virus and disease. Through the analysis of exam room conversations with specific discussion…

  • Risk in the Age of COVID: Key Themes from Upcoming Whitepaper

    In the exam room, discussion of COVID-19-related risks are evolving as we learn more about the underlying characteristics of this virus and disease. Through the analysis of >1,400 exam room conversations with specific discussion of COVID-19, our research team has…